The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Please click on the speaker’s name to download pdf presentations of the seminars.
Biosimilars in breast cancer – the next challenge (sponsored by an educational grant from Amgen)
J. Goncalves; H. Rolighed Christensen; R. Bartsch
Anticoagulation – from theory to practice (sponsored by an educational grant from Bayer)
K. Malá; S. Steurbaut; B. van den Bemt
Biosimilars in cancer care – the next challenge (financial support was provided by Pfizer Limited as a Medical and Educational Goods and Service)
R. Giuliani; P. Cornes; G. Befrits
Synergy breakfast event – The power of automation (sponsored by an educational grant from Omnicell)
G. Honeywell; G. Henneré; M. J. Tamés
The essentials of biologicals – past, present and future (sponsored by an educational grant from Sandoz)
Harald H. Sitte; S. Simoens; P. Troein
Keynote 1 – A fact-based view on global health and infectious diseases
H. Nordenstedt
Keynote 2 – We have a dream!
C. McKay; J. Underhill
Keynote 3 – Marketing the hospital pharmacist profession
C. Picton
IG1 – The efficient pharmacist prioritising tasks and designing processes
R. Fernandes; A. Jacklin
IG2- The productive pharmacist – process and workforce planning
V. Zardet; M. Frachette
IG3 – The effective pharmacist – the team member
A. Sinclair; P. Mirbod
SPD1 – Medicines shortages – a reality check?
T. Hoppe-Tichy; N. Linde-Laursen
SPD2 – Bridging the efficacy/effectiveness gap
A. Gouveia; N. Groessmann
PC1 – Clinical trial regulation and ethical committees
I. Krämer; C. M. Romeo Casabona
PC2 – Hospital mergers and the centralisation of production services
A. Vermes; S. Crauste-Manciet
PC3 – Hospital pharmacists involved in ATPM and in Risk Assessment
A. De Goede; K. Saadat
PC4 – Quality and risk assessment of medicines for children
D. Zanon; A. Lowey
PC5 – Presentation and workshop dedicated to the implementation of the Resolution [CM/Res(2016)2] on good reconstitution practices in European hospitals
H. Scheepers; P. Le Brun
CPS1 – Managing polypharmacy – thinking outside the box
M. Wilson; C. Morrison
CPS2 – Providing pharmaceutical care for patients admitted to their own bedroom
M. Rom; C. Endrell
CPS3 – Antimicrobial stewardship – growing a positive culture
U. Dumpis; J. Thern
PQ1 – Materiovigilance (UDI – tracing – reporting)
V. Nys; B. Lambaux
PQ2 – Ready to administer drugs – is everything under control?
S. Sauer; O. Delgado Sánchez
ER1 – Clinical Trials in Paediatric Haemato-oncology: different ways for HPs to participate
M-B. Aretin; F. Engels
ER2 – Clinical Pharmacy Services: Absence of evidence is not evidence of absence
L.J. Kjeldsen; J. Krska
ER3 – The art of writing an abstract and getting in accepted
G. Stemer; T. Hoppe-Tichy
Workshop 1 – The pharmacist’s role in the drugs and therapeutics committee
N. Martinez-Lopez de Castro; H. Plet
Workshop 2 – Assessment and clinical importance of pharmacist recommendations
H. Toss; U. Gillespie
Workshop 3 – Check of medication appropriateness (COMA): an instrument to implement clinical guidelines in practice
T. Van Nieuwenhuyse; C. Quintens
Hospital pharmacy in Sweden, highlights and curiosities
K-J. Lindner; U. Gillespie; A. Bergkvist Christensen
Student Programme: An evidence based approach to developing an individualised patient care plan
A. Tonna; K. Gibson Smith